Trading Summary - July 20. A pivotal day for $SFLM -

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
200
Trading Summary - July 20.

A pivotal day for $SFLM - first with a new bidder coming in at .0007 with 7.5M - above the increased bid of 71M at .0006 - and then with no fills in over 1.5 hours using the funds to hit the ask at .0008 for 7.5M to ensure getting in before the .0010+ break.

The ask at .0008 had already been varied considerably by the basher / scammer who had topped it up from 11M on uptick to 16M - but after the 7.5M buy he cancelled some and commented positively about the buy.

At the close, 3.7M remained in non-expired day trades.

There have been no significant fills at .0006 in several days since the last time the .0008s were almost gone with 3M left.

OTC market top traders again choose to spend part of the day elsewhere on other Watch List tickers also breaking out or reloading: $PSRU $DGWR $IJJP $INQD $ECOX $INCC $ENZC.

Cash extracted with profits from these can then be used later to continue to move $SFLM up towards the .01+ break.

Ahead expect more former new interest bid sitters to buy successive asks - and increased attention from the existing OTC market top traders of it - before the anticipated record 2022 Q2 filing.

Overall, 13.5M shares were traded today on $SFLM - the majority in a single buy at .0008 in late session.

My assessment on the Public Offering - which is working out as intended - is covered in detail in the latest DD (see link below).

Top traders of $SFLM are playing a waiting game as evidenced by the 500>1000+ views on the main board for it here every day. They spent part of the day on the "coming off the bottom" breakout tickers listed above.

It makes little difference to the OTC market top long-term continuous traders of $SFLM where they buy in the .0008 > .0050 range as we are expecting .02+ eventually - although of course any low level flipping profits will be different.

If people fail to hit the ask aggressively across multiple ticks at the open, legacy debt holders will sell and Public Offering investors will continue to convert a portion of their holdings to free at current levels .0008 > .0015.

We still need to see significant buys across several asks at the open that are crucial to getting the breakout to the .01 > .02+ range started.

The Share Structure was updated on July 12, 2022 showing no dilution whatsoever in the last 39 days. Prior to that, there has been no significant dilution in 2021 or 2022 compared to the volume traded in any period of increase - as explained in the DD (see link below).

Key Points - 2022 Q1 here:

https://investorshangout.com/post/view?id=6403329

Corporate Video:

https://twitter.com/i/status/1512415744105099269

Key Points - CEO 16th Update Video:

https://investorshangout.com/post/view?id=6419422

CEO 17th Update Video - published June 17, 2022:

https://www.youtube.com/watch?v=5vGvsuSg1vA

Latest DD - updated July 17, 2022 - here:

https://investorshangout.com/post/view?id=6439057

$SFLM was the #1 Top Profit Pick and #1 Top Banked Profit stock of 2021 and 2020 on my Watch List.

It is also my #1 Top Profit Pick for the whole of 2022 into 2023 for the patient.

Major catalysts ahead in 2022 are:

- Continued excellent revenue growth from the core Jewelry Division.

- Updates on the Metaverse Division.

- Updates on the NFT Division.

- Updates on Bitcoin activities.

- Acquisitions of other collectibles companies - some already in discussions.

- OTCQB / NASDAQ uplisting or IPO.

- Further steps / share reductions in the Shareholder Protection Initiative.

- Anticipated record breaking 2022 Q2 filing.

Watch out for PRs / updates ahead on one or more of the following:

- Further updates on the Metaverse Division.

- Next step in the Shareholder Protection Initiative.

- Record Q2 and progress so far in Q3.

Week 29 is already shaping up to be very good - so may be in the $250K > $300K+ range - update to follow later.


SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AllyGPO Shines as Top Innovator in Health Tech

Updated Category News Views 2

Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...

Continue Reading
Nashville Benefit Concert Supports Animal Rescue Mission

Updated Category News Views 1

Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...

Continue Reading
MADD, Uber Rally at Capital Invitational for Safe Choices

Updated Category News Views 2

Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...

Continue Reading
India's First Upright Proton Therapy System Unveiled

Updated Category News Views 3

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 2

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading
1M+ California Homes Face Extreme Wildfire Risk Revealed

Updated Category News Views 2

Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...

Continue Reading
Verdafero Gains Ground in Sustainable Hospitality

Updated Category News Views 1

Verdafero's Latest Milestone: A Broader Environmental Reach It’s a day like today that makes you pause and realize that businesses in the hospitality space aren’t just about fluff and fancy lobbies anymore. They've got a new wave of responsibilities, especially with the globe pretty much on fire, literally and figuratively. Verdafero, a name not new to function and...

Continue Reading
BrightPlan's AI-Powered Growth: Series C Fuel

Updated Category News Views 2

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Continue Reading
Innventure Faces Major Lawsuit Amidst Market Turmoil

Updated Category News Views 0

The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...

Continue Reading
Tiger Group to Auction Huge Window Manufacturing Plant

Updated Category News Views 1

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Continue Reading

Top 5 Most Recently Viewed Articles

Palomar Holdings Set for Release of Q3 2024 Financial Results

Updated Category News Views 214

Palomar Holdings Announces Financial Results Release Palomar Holdings, Inc. (NASDAQ: PLMR) has recently made an exciting announcement regarding its upcoming financial results. The company will release its financial results for the third quarter of 2024 after the market closes on a specified date, which is the forthcoming Monday. This is a crucial moment for investors and...

Continue Reading
Wall Street Trends: Insights on High-Performing Stocks

Updated Category News Views 453

Wall Street Experiences a Retreat from Record Highs This week, Wall Street showed signs of a retreat from its record highs. Key influences included cautious profit outlooks from major companies and economic concerns highlighted by the Federal Reserve. The recent forecast from a leading retail giant raised flags about consumer spending amid uncertainty caused by inflation...

Continue Reading
Elevai Labs Reports Positive Clinical Study Results

Updated Category News Views 109

Elevai Labs Inc. Shares Promising Clinical Study Results Elevai Labs, Inc. (NASDAQ: ELAB), a leader in the field of medical aesthetics, has announced the successful completion of a clinical study that evaluated the effectiveness of Elevai exosomes on facial appearance. The internal review of the study's data shows that Elevai enfinity™ is both safe and well-tolerated,...

Continue Reading
Barratt Developments Sees Profits Fall Amid Market Challenges

Updated Category News Views 77

Barratt Developments Sees Decline in Profits Shares of Barratt Developments (LON:BDEV) have recently fallen after the company reported a significant drop in profits for the year ending in June. This decline comes as the housing sector grapples with a challenging market environment. Financial Summary In the latest trading update, Barratt's shares were down by 1.8%, trading...

Continue Reading
Analysts Boost Expectations for American Healthcare REIT Stock

Updated Category News Views 149

KeyBanc Raises Price Target for American Healthcare REIT Recently, KeyBanc Capital Markets increased its price target for American Healthcare REIT, Inc (NYSE: AHR) to $28, up from $27, while keeping an Overweight rating on the stock. This change comes after the company announced a larger follow-on common equity offering aimed at acquiring the remaining interest in Trilogy...

Continue Reading